BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17106567)

  • 1. Utilization of complement testing in clinical medicine.
    Abdul-Aziz K; Faizal AA
    Saudi Med J; 2006 Nov; 27(11):1775-7. PubMed ID: 17106567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigation of the complement system in clinical practice].
    Frémeaux-Bacchi V; Dragon-Durey MA; Blouin J; Mouthon L; Fridman WH
    Ann Med Interne (Paris); 2003 Dec; 154(8):529-40. PubMed ID: 15037829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic tests: C4].
    Kitamura H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():84-7. PubMed ID: 16111195
    [No Abstract]   [Full Text] [Related]  

  • 4. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR; Forristal J; Beischel L
    J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus, partial lipodystrophy and hypocomplementemia.
    Jasin HE
    J Rheumatol; 1979; 6(1):43-50. PubMed ID: 439110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of complement components in disease.
    Luskin AT; Tobin MC
    Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complement analysis tests].
    Mollnes TE; Nielsen EW; Høgåsen K; Mellbye OJ
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):211-3. PubMed ID: 8430403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
    Garred P; Mollnes TE; Thorsteinsson L; Erlendsson K; Steinsson K
    Scand J Immunol; 1990 Jan; 31(1):59-64. PubMed ID: 2300790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
    Kerr LD; Adelsberg BR; Schulman P; Spiera H
    Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.
    Ceribelli A; Andreoli L; Cavazzana I; Franceschini F; Radice A; Rimoldi L; Sinico RA; Carlsson M; Wieslander J; Tincani A
    Ann N Y Acad Sci; 2009 Sep; 1173():427-34. PubMed ID: 19758182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
    Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
    Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
    Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
    Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-specific immune mechanisms. The alternate pathway in the complement system].
    Schön K; Koeppe HW
    Med Klin; 1979 Mar; 74(13):461-9. PubMed ID: 431472
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of serum complement hemolytic activity--effect of separation and storage conditions of the serum and reference values].
    Okumura N; Kameko M; Kanai M
    Rinsho Byori; 1983 Nov; 31(11):1219-23. PubMed ID: 6672294
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of complement proteins in the umbilical cord in the early diagnosis of hereditary angioneurotic edema].
    Ferlazzo B; Barrile A; Crisafi A; Quattrocchi P; Bonanno D; Giacobbe G; Sorge R
    Recenti Prog Med; 1991 Jan; 82(1):29-30. PubMed ID: 2028073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.